| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 7, 2022 | PAVM Pavmed Inc. | Glennon Michael J | Director | Buy | 250,000 | $0.64 | $161,008.80 | +117.9% | -22.6% | -68.8% | |
| Dec 6, 2022 | BRKR Bruker Corp | Packer Richard A49 | Director | Sell | 20,000 | $66.18 | $1,323,660.00 | -25.0% | +12.9% | +2.3% | |
| Dec 5, 2022 | ATEC Alphatec Holdings, Inc. | Sponsel David61 | EVP, Sales | Sell | 10,000 | $9.88 | $98,800.00 | -1.8% | +60.6% | +31.4% | |
| Dec 5, 2022 | RMD Resmed Inc | Pendarvis David68 | Chief Administrative Officer | Sell | 1,500 | $229.81 | $344,715.00 | -1.5% | -0.1% | -26.6% | |
| Dec 5, 2022 | RBOT Vicarious Surgical Inc. | Kelly William John85 | CFO And Treasurer | Sell | 4,285 | $3.03 | $12,974.55 | -1.3% | -6.4% | -90.0% | |
| Dec 5, 2022 | IDXX Idexx Laboratories Inc /de | Junius Daniel M | Director | Sell | 3,046 | $424.91 | $1,294,275.86 | -50.6% | +15.1% | +22.9% | |
| Dec 5, 2022 | ELUT Elutia Inc. | Highcape Capital, L.P. | Director, 10% Owner | Buy | 735,000 | $4.75 | $3,491,250.00 | +15.1% | +17.3% | -37.9% | |
| Dec 5, 2022 | IRMD Iradimed Corp | Vuoto Anthony | - | Sell | 1,000 | $28.55 | $28,547.40 | -6.6% | +34.2% | +47.3% | |
| Dec 5, 2022 | ELUT Elutia Inc. | Ferguson Matthew | Chief Financial Officer | Buy | 28,000 | $4.51 | $126,400.00 | +33.5% | +17.3% | -37.9% | |
| Dec 5, 2022 | INSP Inspire Medical Systems, Inc. | Ban Randy68 | Chief Commercial Officer | Sell | 10,333 | $235.87 | $2,437,264.22 | -43.4% | +13.2% | -36.8% | |
| Dec 5, 2022 | MXCT Maxcyte, Inc. | Ross Thomas M.82 | EVP, Global Sales &Marketing | Sell | 29,133 | $5.81 | $169,303.47 | -100% | -18.8% | -3.5% | |
| Dec 5, 2022 | CATX Perspective Therapeutics, Inc. | Hunt Jonathan Robert61 | Chief Financial Officer | Buy | 85,404 | $0.38 | $32,501.40 | +32.1% | +27.4% | -23.1% | |
| Dec 4, 2022 | EKSO Ekso Bionics Holdings, Inc. | Sherman Steven72 | Executive Chair | Sell | 10,576 | $1.28 | $13,491.80 | -1.4% | +15.5% | +24.8% | |
| Dec 2, 2022 | INFU Infusystem Holdings, Inc | Lehman Gregg Owen68 | Director | Sell | 25,000 | $8.74 | $218,580.00 | -98.6% | +7.3% | +13.9% | |
| Dec 2, 2022 | SYK Stryker Corp | Lobo Kevin | Chair And CEO | Sell | 67,232 | $239.68 | $16,114,298.84 | -26.7% | +7.8% | +22.5% | |
| Dec 2, 2022 | TMCI Treace Medical Concepts, Inc. | Owens Daniel E.52 | Chief Human Resources Officer | Sell | 5,625 | $25.00 | $140,625.00 | -20.8% | -14.7% | -61.2% | |
| Dec 2, 2022 | IDXX Idexx Laboratories Inc /de | Szostak M Anne | Director | Sell | 740 | $428.55 | $317,127.00 | -37.0% | +9.4% | +10.9% | |
| Dec 2, 2022 | IRTC Irhythm Holdings, Inc. | Murphy Patrick Michael55 | CLO &EVP Ra/ Qa Mrktacs &Gov | Sell | 1,704 | $106.78 | $181,953.12 | -6.7% | +6.8% | -19.6% | |
| Dec 2, 2022 | LMAT Lemaitre Vascular Inc | Jasinski Lawrence J62 | Director | Sell | 10,000 | $47.07 | $470,697.00 | -52.9% | +7.9% | +14.1% | |
| Dec 2, 2022 | TMDX Transmedics Group, Inc. | Carey John F | VP Of Operations | Sell | 13,000 | $62.99 | $818,872.61 | -42.3% | +24.5% | +16.1% | |
| Dec 1, 2022 | ARAY Accuray Inc | Chew Jesse57 | SVP, General Counsel | Sell | 5,976 | $2.10 | $12,525.70 | -2.4% | +36.7% | +21.0% | |
| Dec 1, 2022 | OM Outset Medical, Inc. | Trigg Leslie84 | Chair And CEO | Sell | 30,000 | $20.85 | $625,500.00 | -4.9% | +2.1% | -74.3% | |
| Dec 1, 2022 | IDXX Idexx Laboratories Inc /de | Turner Kathy V62 | Senior Vice President | Sell | 3,000 | $436.00 | $1,308,000.00 | -30.2% | +6.8% | +9.9% | |
| Dec 1, 2022 | ARAY Accuray Inc | Spine Patrick62 | SVP, Chief Admin Officer | Sell | 5,176 | $2.10 | $10,848.90 | -2.4% | +36.7% | +21.0% | |
| Dec 1, 2022 | LMAT Lemaitre Vascular Inc | Roush John A49 | Director | Sell | 7,500 | $46.65 | $349,840.50 | -48.2% | +6.0% | +13.5% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.